Swedish Orphan Biovitrum AB (publ) Capital Markets Day Transcript
()-&
Welcome to Sobi's Capital Markets Day 2020. Thank you, all, for joining us today. A warm welcome to all viewers and also everyone that is participating over the phone. I am Paula Treutiger, Head of Communications and Investor Relations. Please pay attention to our forward-looking statements.
Today, you will hear from CEO, Guido Oelkers; Ravi Rao, Head of R&D; Norbert Oppitz, Head of Immunology and International; and finally, CFO, Henrik Stenqvist. They will give you an update on Sobi's future growth potential and also financially.
You see the agenda on the screen. After the first 2 presentations, we will have a break. After, we continue. We will end with a Q&A session and aim to finish at 4:00 o'clock.
In order to ask questions, you need to dial in on the conference call or send in your questions via the webcast site.
With that, I would like to hand over to Guido.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |